LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments.

    Jafari, Anya / Dadkhahfar, Sahar / Perseh, Sahra

    Critical reviews in oncology/hematology

    2020  Volume 151, Page(s) 102982

    Abstract: SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment ... ...

    Abstract SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents.
    MeSH term(s) Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/drug therapy ; Drug Interactions ; Humans ; Pandemics ; Pneumonia, Viral/drug therapy ; SARS-CoV-2
    Chemical Substances Antineoplastic Agents
    Keywords covid19
    Language English
    Publishing date 2020-05-12
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 605680-5
    ISSN 1879-0461 ; 0737-9587 ; 1040-8428
    ISSN (online) 1879-0461
    ISSN 0737-9587 ; 1040-8428
    DOI 10.1016/j.critrevonc.2020.102982
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

    Jafari, Anya / Dadkhahfar, Sahar / Perseh, Sahra

    Crit Rev Oncol Hematol

    Abstract: SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment ... ...

    Abstract SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #400529
    Database COVID19

    Kategorien

  3. Article ; Online: Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

    Jafari, Anya / Dadkhahfar, Sahar / Perseh, Sahra

    Critical Reviews in Oncology/Hematology

    2020  Volume 151, Page(s) 102982

    Keywords Oncology ; Geriatrics and Gerontology ; Hematology ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 605680-5
    ISSN 0737-9587 ; 1040-8428
    ISSN 0737-9587 ; 1040-8428
    DOI 10.1016/j.critrevonc.2020.102982
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top